US 12252544
Anti-CD63 antibodies, conjugates, and uses thereof
granted A61KA61K2039/505A61K38/47
Quick answer
US patent 12252544 (Anti-CD63 antibodies, conjugates, and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K2039/505, A61K38/47, A61K48/00, A61P